Clinical trials have shown better efficacy of escitalopram over citalopram, and review-based
economic models the cost-effectiveness of escitalopram vs. citalopram (brand and generic).
No head-to-head clinical trial has, however, evaluated the cost-effectiveness of both drugs
so far. The aim of this study was to assess the relative cost-effectiveness of escitalopram
compared with citalopram in patients with major depressive disorder. An economic
evaluation was conducted alongside a double-blind randomized clinical trial conducted by …